Verona Pharma plc Update On Agm Procedure

 
TIDMVRP 
 
   LONDON, April 08, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) 
(Nasdaq: VRNA) ("Verona Pharma" or the "Company"), a clinical-stage 
biopharmaceutical company focused on developing and commercializing 
innovative therapies for respiratory diseases, provides an update on its 
upcoming Annual General Meeting ("AGM"), scheduled to be held at the 
offices of Shakespeare Martineau at 60 Gracechurch Street, London EC3V 
0HR, United Kingdom at 10.30 a.m. on April 16, 2020. 
 
   The Company currently plans to hold its AGM as scheduled, however given 
the UK Government's present restrictions on public gatherings of more 
than two people, the Board requests shareholders to vote by proxy rather 
than attend the AGM in person. Any shareholders seeking to attend the 
AGM in person will be refused entry. 
 
   By way of reminder, the deadline for delivery of completed proxy forms 
by holders of the Company's ordinary shares is 10.30 a.m. on April 14, 
2020. The equivalent deadline for proxy voting by holders of the 
Company's American Depository Shares is 10 a.m. on April 9, 2020. 
 
   Verona Pharma continues to review the UK Government's restrictions and 
recommends that shareholders monitor the Company's website and 
announcements for any updates in relation to the AGM. In the event that 
its AGM arrangements have to change, the Company will issue a further 
communication via a regulatory information service. 
 
   A copy of our 
https://www.globenewswire.com/Tracker?data=8Pw5dDrrYyta7egTU1c8Q0pGi-28v5Fn0lNHPqfZLvGl1jvks4H_ksJ7KdtPGyQn-2de_teBBtPSAGCBrgj9jGWzMWzLsQb9uqbdJcEhBw0uGtQgVcoB4P0dN9VM84cTxTuCVusVL2uDuLBSqIRblQUiW5T5r-79fAFZ754xxf9drRQVq9150B0gQ2fBmDCAtflsnCfkNNto5IHSztzFxH0wDNOrupr9MZl4loCLRM4= 
AGM Notice and 
https://www.globenewswire.com/Tracker?data=IYfS9qEzVhJSElJbcrFnP-UHTdCSZdhK8icpCnluDUcE1UilYF7zlClhsK_7tijJD-J_TJ8UEzmtDcm7E8JUITGmQoRlqQAbzZO1bebVYiDJAQIPJcvcTIRGlObmYjYhbnaEWgXapMErl5kLk3dFPWod9MtUfVaFAkUDW3aKwjQihyfIEdE8G3iQENHYHN8xe5DeSQPfHaYjcb0yMw5NknPZYuk8FiqgSJsigX3gCCk= 
Annual Report are available on the Company's website within the 
Investors section, www.veronapharma.com. 
 
   For further information, please contact: 
 
 
 
 
Verona Pharma plc                             Tel: [phone] 
--------------------------------------------  ------------------------ 
Victoria Stewart, Director of Communications  [e-mail] 
--------------------------------------------  ------------------------ 
 
N+1 Singer                                    Tel: [phone] 
--------------------------------------------  ------------------------ 
(Nominated Adviser and UK Broker) 
 Aubrey Powell / George Tzimas / Iqra 
 Amin (Corporate Finance) 
 Tom Salvesen (Corporate Broking) 
--------------------------------------------  ------------------------ 
 
 
 
 
 
 

(END) Dow Jones Newswires

April 08, 2020 02:00 ET (06:00 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.